Evoke Pharma (EVOK) Reports In-Line Q1 EPS

Evoke Pharma (NASDAQ: EVOK) reported Q1 EPS of ($0.55), in-line with the analyst estimate of ($0.55).

For earnings history and earnings-related data on Evoke Pharma (EVOK) click here.

You May Also Be Interested In

• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• Ares Management, L.P. (ARES) PT Raised to $153 at TD Cowen
• Bernstein SocGen Reiterates Outperform Rating on Fervo Energy (FRVO)